Douglas A. Drossman
University of North Carolina at Chapel Hill
Quality of lifePsychiatryInternal medicineBiopsychosocial modelSurgeryPsychosocialHealth careIntensive care medicinePhysical therapyIrritable bowel syndromeDiseaseMEDLINEAbdominal painConstipationPopulationIn patientFamily medicineClinical psychologyMedicineGastroenterology
444Publications
103H-index
31.2kCitations
Publications 440
Newest
#1Laurie Keefer (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 40
#2Sarah Ballou (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 17
Last. Brjánn Ljótsson (KI: Karolinska Institutet)H-Index: 55
view all 6 authors...
Abstract null Background and Aims null This Rome Foundation Working Team Report reflects the consensus of an international, interdisciplinary team of experts regarding the use of behavioral interventions in patients with disorders of gut-brain interaction (DGBI), specifically Brain-Gut Behavior Therapies (BGBT). null Methods null The committee members reviewed the extant scientific literature and whenever possible, addressed gaps in this literature through the lens of their clinical and scientif...
1 CitationsSource
#1Jane LesermanH-Index: 65
#2Douglas A. DrossmanH-Index: 103
Last. Zhiming LiH-Index: 16
view all 3 authors...
Source
#1Douglas A. Drossman (UNC: University of North Carolina at Chapel Hill)H-Index: 103
#2Lin Chang (UCLA: University of California, Los Angeles)H-Index: 73
Last. Ami D. Sperber (BGU: Ben-Gurion University of the Negev)H-Index: 31
view all 10 authors...
Background & Aims null Over several decades, changes in health care have negatively impacted meaningful communication between the patient and provider and adversely affected their relationship. Under increasing time pressure, physicians rely more on technology than face-to-face time gathering data to make clinical decisions. As a result, they find it more challenging to understand the illness context and fully address patient needs. Patients experience dissatisfaction and a diminution of their r...
Source
#1Hans Törnblom (University of Gothenburg)H-Index: 33
#2Douglas A. Drossman (UNC: University of North Carolina at Chapel Hill)H-Index: 103
Psychopharmacologic therapies are beneficial in reducing symptoms when treating irritable bowel syndrome (IBS) and other disorders of gut-brain interaction (DGBI). Noradrenaline, serotonin, and dopamine are neurotransmitters of key importance in psychopharmacology and pain-reduction mechanisms. The first-line (tricyclic antidepressants, serotonin noradrenaline reuptake inhibitors, selective serotonin reuptake inhibitors) and second-line (atypical antipsychotics, delta-ligand agents, low-dose nal...
1 CitationsSource
#1Benjamin Nulsen (UCLA: University of California, Los Angeles)H-Index: 2
#2Wendi LeBrett (UCLA: University of California, Los Angeles)H-Index: 1
Last. Lin Chang (UCLA: University of California, Los Angeles)H-Index: 73
view all 4 authors...
Background null Central neuromodulators are an effective treatment for irritable bowel syndrome (IBS) but may be used less frequently than other therapies. null Aims null To survey gastroenterologists in the United States (US) about their use of neuromodulators in patients with IBS. null Methods null A 23-question survey was distributed to gastroenterologists in the United States. Comparisons in prescribing practices were conducted between (a) gastroenterologists who were "high prescribers" vers...
1 CitationsSource
#1Ami D. Sperber (BGU: Ben-Gurion University of the Negev)H-Index: 31
#2Tamar Freud (BGU: Ben-Gurion University of the Negev)H-Index: 13
Last. Shrikant I. Bangdiwala (McMaster University)H-Index: 75
view all 19 authors...
BACKGROUND AND AIMS Conditions such as irritable bowel syndrome (IBS), functional dyspepsia and functional constipation are among the prevalent gastrointestinal disorders classified as disorders of gut brain interaction (DGBI), which can adversely affect the lives of sufferers. This study aimed to assess the degree and consequences of overlapping DGBI in a large population-based global scale. METHODS Internet survey data from 54,127 adults (49.1% females) in 26 countries were analyzed by 4 GI an...
Source
#1Jordyn Feingold (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 3
#2Douglas A. DrossmanH-Index: 103
Last. Laurie Keefer (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 40
view all 7 authors...
BACKGROUND An effective patient-physician relationship (PPR) is essential to the care of patients with irritable bowel syndrome (IBS). After developing a PPR questionnaire for patients, we sought to develop and validate an IBS-specific instrument to measure physician expectations of the PPR. METHODS We conducted focus groups about PPRs among 15 clinicians who treat patients with IBS from community and academic centers. Qualitative analysis was used to generate the Patient-Physician Relationship ...
2 CitationsSource
#1Jordyn Feingold (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 3
#2Douglas A. DrossmanH-Index: 103
Stigma, defined as social devaluation based on negative stereotypes toward a particular population, is prevalent within health care and is a common phenomenon in disorders of gut-brain interaction (DGBI). Characteristically, DGBI including functional dyspepsia (FD) lack a structural etiology to explain symptoms, have high psychiatric co-morbidity, and respond to neuromodulators traditionally used to treat psychopathology. As a result, these disorders are frequently and wrongly presumed to be psy...
9 CitationsSource
#1Ami D. Sperber (BGU: Ben-Gurion University of the Negev)H-Index: 31
#2Shrikant I. Bangdiwala (McMaster University)H-Index: 75
Last. Olafur S. Palsson (UNC: University of North Carolina at Chapel Hill)H-Index: 50
view all 48 authors...
Abstract Background & Aims Although functional gastrointestinal disorders (FGIDs), now called disorders of gut–brain interaction, have major economic effects on healthcare systems and adversely affect quality of life, little is known about their global prevalence and distribution. We investigated the prevalence of and factors associated with 22 FGIDs, in 33 countries on 6 continents. Methods Data were collected via the internet in 24 countries, personal interviews in 7 countries, and both in 2 c...
163 CitationsSource
#1Christopher J Black (University of Leeds)H-Index: 13
#2Douglas A. Drossman (UNC: University of North Carolina at Chapel Hill)H-Index: 103
Last. Alexander C. Ford (University of Leeds)H-Index: 86
view all 5 authors...
Gastrointestinal symptoms are highly prevalent, but many people who have them will have no organic explanation for their symptoms. Most of these people will be labelled as having a functional gastrointestinal disorder, such as irritable bowel syndrome, functional dyspepsia, or functional constipation. These conditions affect up to 40% of people at any one point in time, and two-thirds of these people will have chronic, fluctuating symptoms. The pathophysiology of functional gastrointestinal diso...
27 CitationsSource